A Phase 2 Study of Home Care Following Autologous Hematopoietic Stem Cell Transplantation

Conditions

• Well-being of Caregivers (Caregiver Strain Index)

Eligibility Criteria

Sex

ALL

Age

18 Years - 80 Years

Healthy Volunteers

Not accepted

Interventions

• home care — OTHER
  This is the interventional arm where patients receive the transplant care in their homes.

Study Details

This is a research study to compare the well-being (caregiver strain index) of caregivers of patients receiving home vs standard care after autologous hematopoietic stem cell transplant.

Key Dates

Start date

Sep 28, 2018

Status verified

Mar 2025

Primary completion

Jan 31, 2026

Completion

Jan 30, 2027

Study Design

Enrollment

150 participants (estimated)

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

SUPPORTIVE_CARE

Arms

• Experimental: Home care
  This is the arm for patients who receive their transplant care in their homes.
• No Intervention: Hospital Care
  Standard of care for stem cell transplant recipients where the aftercare is done in hospital.
• No Intervention: Clinic Care
  Standard of care for stem cell transplant recipients who live at home but receive aftercare in the daily outpatient clinic.

Primary Outcome Measure

Quality of Life in Caregivers (Caregiver Strain Index) [ Time Frame: 14 days ]

Central Contacts

• Andrea Pires, MS
  919-613-1546
  [email protected]

Locations (1)

Find similar trials in Durham, NC